Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing

Cell Mol Neurobiol. 1991 Feb;11(1):79-89. doi: 10.1007/BF00712801.

Abstract

1. New information identifying nucleotide alterations of human butyrylcholinesterase allows the use of more specific nomenclature for the variants commonly known as atypical, fluoride, silent, and K variant. 2. In addition to suggesting a system of trivial names and abbreviations, we provide a list of formal names that follow the guidelines of the Committee for Human Gene Nomenclature. 3. It is suggested that formal names be included in publications whenever possible.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Butyrylcholinesterase / classification*
  • Butyrylcholinesterase / genetics
  • Cholinesterase Inhibitors / pharmacology
  • DNA / genetics
  • Genes
  • Genetic Variation
  • Genotype
  • Humans
  • Phenotype
  • Polymerase Chain Reaction
  • Sodium Fluoride / pharmacology
  • Substrate Specificity
  • Terminology as Topic

Substances

  • Cholinesterase Inhibitors
  • Sodium Fluoride
  • DNA
  • Butyrylcholinesterase